NCT05416125View on ClinicalTrials.gov

Vyvanse in Children Aged 6 to 12 Years

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2029

Conditions

Obesity, Childhood

Interventions

DRUG

Lisdexamfetamine Dimesylate

Vyvanse treatment

BEHAVIORAL

Lifestyle therapy

Lifestyle treatment

Trial Locations (1)

55414

RECRUITING

University of Minnesota, Minneapolis

All Listed Sponsors

lead

University of Minnesota

OTHER